# Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.

> **NCT03280446** · NA · UNKNOWN · sponsor: **SHERRY Thomas** · enrollment: 30 (estimated)

## Conditions studied

- Vaginal Laxity
- Urinary Incontinence
- Sexual Dysfunction

## Interventions

- **DEVICE:** Intragen fractional radiofrequency with NeuViVa

## Key facts

- **NCT ID:** NCT03280446
- **Lead sponsor:** SHERRY Thomas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-23
- **Primary completion:** 2018-08
- **Final completion:** 2019-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03280446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03280446, "Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03280446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*